Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Dendritic cells (DCs) are the most potent antigen-presenting cells, and have thus been used in clinical cancer vaccines. However, the effects of DC vaccines are still limited, leading researchers to explore novel ways to make them effective. In this study, we investigated whether human monocyte-deri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Tan-Huy, Vo, Manh-Cuong, Lakshmi, Thangaraj Jaya, Ahn, Seo-Yeon, Kim, Mihee, Song, Ga-Young, Yang, Deok-Hwan, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Jung, Sung-Hoon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006865/
https://www.ncbi.nlm.nih.gov/pubmed/35413499
http://dx.doi.org/10.1016/j.tranon.2022.101413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006865/
https://www.ncbi.nlm.nih.gov/pubmed/35413499
http://dx.doi.org/10.1016/j.tranon.2022.101413

Ejemplares similares